1. A recommended analysis for 2 × 2 crossover trials with baseline measurements. (17th September 2014) Authors: Mehrotra, Devan V. Journal: Pharmaceutical statistics Issue: Volume 13:Number 6(2014:Nov./Dec.) Page Start: 376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CAPITAL: Optimal subgroup identification via constrained policy tree search. (7th July 2022) Authors: Cai, Hengrui; Lu, Wenbin; Marceau West, Rachel; Mehrotra, Devan V.; Huang, Lingkang Journal: Statistics in medicine Issue: Volume 41:Number 21(2022) Page Start: 4227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Enabling robust assessment of QTc prolongation in early phase clinical trials. (3rd April 2017) Authors: Mehrotra, Devan V.; Fan, Li; Liu, Fang; Tsai, Kuenhi Journal: Pharmaceutical statistics Issue: Volume 16:Number 3(2017) Page Start: 218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hazard Ratio Estimation in Small Samples. (3rd April 2018) Authors: Xu, Rengyi; Shaw, Pamela A.; Mehrotra, Devan V. Journal: Statistics in biopharmaceutical research Issue: Volume 10:Number 2(2018) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hazard ratio inference in stratified clinical trials with time‐to‐event endpoints and limited sample size. (31st January 2019) Authors: Xu, Rengyi; Mehrotra, Devan V.; Shaw, Pamela A. Journal: Pharmaceutical statistics Issue: Volume 18:Number 3(2019) Page Start: 366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Incorporating baseline measurements into the analysis of crossover trials with time‐to‐event endpoints. (11th June 2018) Authors: Xu, Rengyi; Mehrotra, Devan V.; Shaw, Pamela A. Journal: Statistics in medicine Issue: Volume 37:Number 23(2018) Page Start: 3280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Missing data in clinical trials: control‐based mean imputation and sensitivity analysis. (20th June 2017) Authors: Mehrotra, Devan V.; Liu, Fang; Permutt, Thomas Journal: Pharmaceutical statistics Issue: Volume 16:Number 5(2017) Page Start: 378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Model Averaging Using Likelihoods That Reflect Poor Outcomes for Clinical Trial Dropouts. (2nd January 2020) Authors: Liu, G. Frank; Liu, Fang; Mehrotra, Devan V. Journal: Statistics in biopharmaceutical research Issue: Volume 12:Number 1(2020) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Principal stratum strategy: Potential role in drug development. (23rd February 2021) Authors: Bornkamp, Björn; Rufibach, Kaspar; Lin, Jianchang; Liu, Yi; Mehrotra, Devan V.; Roychoudhury, Satrajit; Schmidli, Heinz; Shentu, Yue; Wolbers, Marcel Journal: Pharmaceutical statistics Issue: Volume 20:Number 4(2021) Page Start: 737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety Profile of the Merck Human Immunodeficiency Virus-1 Clade B gag DNA Plasmid Vaccine With and Without Adjuvants. (17th May 2014) Authors: Quirk, Erin K.; Brown, Elizabeth L.; Leavitt, Randi Y.; Mogg, Robin; Mehrotra, Devan V.; Evans, Robert K.; DiNubile, Mark J.; Robertson, Michael N. Journal: Open forum infectious diseases Issue: Volume 1:Number 1(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗